- Login
- Register & Subscribe
- Langue: EN FR DE
Research & University News
Mayo Clinic researchers identify Parkinson's disease gene mutation
Wednesday 20 July 2011
Researchers from the Mayo Clinic in the US have reported a new gene mutation linked to Parkinson’s disease and identified in a large Swiss family with the disease. The finding was reported in the American Journal of Human Genetics on 19 July.
Location
United States
Convergence starts study of drug for pain
Tuesday 19 July 2011
A recently created spin-out of GlaxoSmithKline Plc has started a Phase 2 study of a new small-molecule treatment for pain that acts against a sodium channel known as Nav1.7. The company is Convergence Pharmaceuticals Ltd.
Location
United Kingdom
Roche says combination therapy met primary endpoint
Sunday 17 July 2011
A combination therapy of pertuzumab, trastuzumab and docetaxel for women with HER2-positive metastatic breast cancer has met its primary endpoint of progression-free survival in a Phase 3 study, according to the trial’s sponsor, Roche.
Location
Switzerland
Evolva reports on drug for diabetic complications
Friday 15 July 2011
Evolva Holding SA has successfully completed a Phase 1 study of a new small molecule compound that is being positioned to treat people with diabetes at risk of vascular or renal complications. The study involved 32 volunteers.
Location
Switzerland
EU project to study cell and gene therapy in heart disease
Thursday 14 July 2011
The European Commission has awarded €5.3 million over four years to a consortium led by Ark Therapeutics Group Plc to investigate the possible use of gene and cell therapy, along with stents, in the treatment of coronary heart disease.
Location
United Kingdom
Ipsen and Salk Institute renew research agreement
Tuesday 12 July 2011
Ipsen SA and The Salk Institute for Biological Studies of the US are renewing for another three years, their research collaboration to explore the biology of proliferative and degenerative diseases. Financial details were not disclosed.
Location
France
SuppreMol to test protein in lupus
Monday 11 July 2011
Venture-capital backed SuppreMol GmbH has announced the start of a Phase 2a study of a recombinant protein for systemic lupus erythematosus. This follows FDA approval in March of an antibody therapeutic for lupus from GSK, the first new drug for the disease since 1955.
Location
Germany
Novel antibody against influenza reported
Friday 8 July 2011
A novel monoclonal antibody that is said to have the potential to neutralise most group 2 influenza A viruses has been described in a paper in the journal Science. The research was conducted by Crucell NV and The Scripps Research Institute of the US.
Location
Netherlands
Sanofi stops Multaq trial in AF
Thursday 7 July 2011
Sanofi SA has stopped a Phase 3b trial of its antiarrhythmic, Multaq (dronedarone), in patients with permanent atrial fibrillation following a significant increase in cardiovascular events in those receiving the drug.
Location
France
Study suggests new targeted approach for MS
Tuesday 5 July 2011
A study published in Nature Medicine has suggested that inhibiting a receptor called death receptor-6 may represent a novel approach for the treatment of multiple sclerosis. The study was undertaken by researchers at Biogen Idec of the US.
Location
United States
Select a News Category
Recent Appointments
Pascale Witz to head strategic development at Sanofi
Monday May 6 2013
Srinivas Akkaraju joins Sofinnova Ventures
Monday May 6 2013
Vicente Anido nominated to Nicox board
Monday May 6 2013
Jeremy Farrar named director of the Wellcome Trust
Monday May 6 2013
Harry Kirsch becomes CFO at Novartis
Monday May 6 2013